(Q79224123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

J Chamberlain-Banoub

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

J W Neal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

W Song

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

M Mizuno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

C L Harris

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

294-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis

20 December 2019

cites work

1 reference

12 December 2020

Ultrastructural Localization of Immune Complexes (IGG and C3) at the End-Plate in Experimental Autoimmune Myasthenia Gravis

1 reference

12 December 2020

Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors

1 reference

12 December 2020

Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity

1 reference

12 December 2020

C5 gene influences the development of murine myasthenia gravis

1 reference

12 December 2020

An electrophysiological study of the effects of myasthenia gravis sera and complement on rat isolated muscle fibres

1 reference

12 December 2020

Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients

1 reference

12 December 2020

Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis

1 reference

12 December 2020

Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting

1 reference

12 December 2020

Changes in serum complement activity in patients with myasthenia gravis

1 reference

12 December 2020

Pexelizumab -- a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass.

1 reference

12 December 2020

Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy

1 reference

12 December 2020

Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.

1 reference

12 December 2020

The complement system: an overview

1 reference

12 December 2020

Complement. First of two parts

1 reference

12 December 2020

Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria

1 reference

12 December 2020

Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificit

1 reference

12 December 2020

Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies

1 reference

12 December 2020

Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

1 reference

12 December 2020

Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice

1 reference

12 December 2020

The role of antibodies in myasthenia gravis

1 reference

12 December 2020

Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection

1 reference

12 December 2020

Complement therapeutics; history and current progress.

1 reference

12 December 2020

Genetic Evidence for Involvement of Classical Complement Pathway in Induction of Experimental Autoimmune Myasthenia Gravis

1 reference

12 December 2020

Deficiency of the complement regulator CD59a enhances disease severity, demyelination and axonal injury in murine acute experimental allergic encephalomyelitis

1 reference

12 December 2020

Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis

1 reference

12 December 2020

The human complement factor H: functional roles, genetic variations and disease associations

1 reference

12 December 2020

Pathophysiology of myasthenia gravis

1 reference

12 December 2020

CD59a is the primary regulator of membrane attack complex assembly in the mouse.

1 reference

12 December 2020

Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis

1 reference

12 December 2020

Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations

1 reference

12 December 2020

Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange

1 reference

12 December 2020

Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis

1 reference

12 December 2020

10.1111/J.1365-2249.2006.03205.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17034582%20AND%20SRC:MED&resulttype=core&format=json

release_f3y77hsy25bflpaenajfet2i3a

20 December 2019

Fatcat ID

0 references

0 references

1 reference